- Tags: myopia
Events
Registration opens for Eyes On Myopia 2026
Virtual event kicks off May 9 in partnership with Woo University, offering up to 5 hours of COPE-accredited CE credits.
Research
High myopes face increased PCO risk with hydrophilic IOLs
Study finds hydrophobic IOLs reduced the risk of PCO in highly myopic eyes by 41%.
Research
Lutein shows potential as myopia management supplement
Preliminary RCT data highlights preservation of choroidal thickness in children taking lutein supplements.
Research
HOYA reports 6-month data on MiYOSMART iQ spectacle lenses for pediatric myopia
Interim results find advanced lens and D.I.M.S. triple enhanced design tech to be twice as effective in controlling axial elongation and disease progression.
Research
Conflicting evidence surrounds astigmatism's role in myopia
Study highlights need for further investigation into the impact of astigmatism on myopia onset and progression.
Products
Euclid Vision launches new SiHy daily disposable lens for myopia
The Be Free Day soft lens for pediatric myopes features BHVI's proprietary dual action, multistep optical design technology.
Research
Research finds limited benefits of outdoor exposure for premyopic children
Protective effect of time outdoors observed in hyperopes and premyopic children after spending >120 minutes/day outside.
Research
Essilor Stellest 2.0 lenses demonstrate superior efficacy in slowing myopia progression
Upgraded FDA-authorized spectacle lenses for pediatric myopia control found to slow axial elongation more effectively after 1 year with advanced technology.
Pipeline
Sydnexis reports phase 3 topline data on SYD-101 eye drop for pediatric myopia
The STAR study met both primary and secondary endpoints for low-dose atropine formulation—just days after the FDA’s NDA rejection.
Research
Myopia may delay DR development and progression
Study used Mendelian randomization to identify a causal relationship between myopia and diabetic retinopathy.
Pipeline
FDA rejects Sydnexis’ NDA for low-dose atropine drop
SYD-101 still has the potential to become the first pharmaceutical option for progressive myopia for patients aged 3 to 14.
Products
Myopia Profile debuts AI virtual assistant for disease management
Ask Kate is trained to deliver real-time, evidence-based responses to help ECPs stay updated on the latest clinical and scientific research.
Events
GMAC launches free myopia awareness toolkit for ECPs
Downloadable resources include take-home brochures, social media graphics, and more to raise awareness and education of pediatric disease progression.
Research
National trial to test preventative atropine drops for pediatric myopia
The University of Houston and The Ohio State University researchers partner on NEI-funded study to test if low-concentrated drops delay onset of myopia.
Research
Do seasonal variations impact myopia treatment efficacy?
Researchers investigate whether the effect of orthokeratology varies base don the season.
Research
Current trajectory of global eyecare access unlikely to meet 2030 goal
Study advocates for global efforts to equitably increase spectacle coverage to achieve 2030 goal.
Research
New data finds increased prevalence of refractive surgery among cataract patients
Clinicians may need to consider new ways of calculating IOL power due to prevalence of high myopia and previous refractive surgery.
Research
Study identifies risk factors for myopic macular degeneration progression
Axial elongation was shown to be a key risk factor for progression, among others.
Pipeline
iVeena submits IND to FDA for pediatric myopia clinical trial
Company plans to initiate a multinational phase 2 study on IVMED-85, a PF and non-atropine daily eye drop intended to improve refraction and decrease AE rates.
Pipeline